Bioscience Advisors, Inc. (Biosci) was founded in January 2011 as a consulting and database firm focused on biopharma alliances. Biosci’s founder, Mark Edwards, has been involved in negotiating and analyzing biopharma alliances since the early days of the biotechnology era in the mid-1980s. In May 2021, Biosci was acquired by Evaluate, the leading provider of commercial intelligence and predictive analytics to pharmaceutical companies and their advisors. The BiosciDB deals database combines the latest biopharma deal announcements and financial updates with unredacted and other SEC-filed alliance contracts, analyzed and searchable by topic and contract provision. BiosciDB is widely used by the biopharma business development & licensing (BD&L) community and is often cited as “the most in-depth” database available. Learn more about BiosciDB at BiosciDB.com.